Covington Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-32,147
Closed -$3.19M 942
2019
Q3
$3.19M Sell
32,147
-1,806
-5% -$172K 0.18% 120
2019
Q2
$3.14M Sell
33,953
-15,672
-32% -$1.49M 0.19% 116
2019
Q1
$4.68M Buy
49,625
+3,807
+8% +$333K 0.29% 99
2018
Q4
$2.94M Sell
45,818
-12,384
-21% -$914K 0.2% 112
2018
Q3
$5.21M Sell
58,202
-6,386
-10% -$564K 0.32% 88
2018
Q2
$5.13M Sell
64,588
-37,289
-37% -$3.1M 0.33% 85
2018
Q1
$9.09M Sell
101,877
-6,021
-6% -$578K 0.6% 52
2017
Q4
$11.3M Buy
107,898
+15,515
+17% +$1.75M 0.7% 43
2017
Q3
$13.5M Buy
92,383
+642
+0.7% +$87.4K 0.89% 31
2017
Q2
$11.9M Buy
91,741
+4,780
+5% +$586K 0.96% 35
2017
Q1
$10.8M Buy
86,961
+1,112
+1% +$133K 0.91% 39
2016
Q4
$9.94M Sell
85,849
-316
-0.4% -$35.2K 0.88% 42
2016
Q3
$9.01M Buy
86,165
+1,695
+2% +$183K 0.82% 43
2016
Q2
$8.33M Buy
84,470
+4,061
+5% +$420K 0.77% 46
2016
Q1
$8.05M Buy
80,409
+1,043
+1% +$107K 0.77% 45
2015
Q4
$9.51M Sell
79,366
-1,839
-2% -$213K 0.93% 34
2015
Q3
$8.78M Sell
81,205
-1,645
-2% -$204K 0.91% 38
2015
Q2
$9.59M Sell
82,850
-861
-1% -$98.4K 0.86% 41
2015
Q1
$9.65M Sell
83,711
-3,585
-4% -$428K 0.93% 38
2014
Q4
$9.77M Sell
87,296
-1,200
-1% -$127K 0.87% 41
2014
Q3
$8.39M Buy
88,496
+1,665
+2% +$150K 0.77% 43
2014
Q2
$7.83M Sell
86,831
-2,479
-3% -$189K 0.71% 51
2014
Q1
$6.23M Sell
89,310
-1,050
-1% -$83.2K 0.61% 60
2013
Q4
$7.63M Buy
90,360
+326
+0.4% +$25.8K 0.78% 43
2013
Q3
$6.94M Sell
90,034
-3,900
-4% -$273K 0.8% 47
2013
Q2
$5.49M Buy
+93,934
New +$5.65M 0.68% 54

Other funds holding CELG

Covington Capital Management's CELG Position: Q4 2019 in Review

Covington Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 32,147 shares — an estimated $3.19M sold.

Covington Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Covington Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Covington Capital Management sold 32,147 Celgene Corp shares in Q4 2019, an estimated $3.19M.
  • Covington Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Covington Capital Management's Celgene Corp position peaked at $13.5M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Covington Capital Management's 13F filing for Q4 2019, filed 18 Feb 2020.